drugset
drugset / Trial / NCT07217899

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT07217899 ↗

Phase 2 Recruiting 140 enrolled University of Michigan
RandomizedParallel-groupTriple-blindPrevention

Summary

This research study is being done to learn what effect a single dose of calcium gluconate will have on blood loss at the time of cesarean delivery in pregnancy patients at high risk for uterine atony.

Timeline

Start
2025-10-20
Primary completion
2026-07
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject calcium gluconate Small molecule 2 g Intravenous

Indications

uterine disorder